Does Post-Transplant Cytomegalovirus Increase the Risk of Invasive Aspergillosis in Solid Organ Transplant Recipients? A Systematic Review and Meta-Analysis.
CMV
aspergillosis
cytomegalovirus
fungal infection
transplantation
Journal
Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827
Informations de publication
Date de publication:
23 Apr 2021
23 Apr 2021
Historique:
received:
09
04
2021
revised:
21
04
2021
accepted:
21
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Cytomegalovirus (CMV) and invasive aspergillosis (IA) cause high morbidity and mortality in solid organ transplant (SOT) recipients. There are conflicting data with respect to the impact of CMV on IA development in SOT recipients. A literature search was conducted from existence through to 2 April 2021 using MEDLINE, Embase, and ISI Web of Science databases. This review contained observational studies including cross-sectional, prospective cohort, retrospective cohort, and case-control studies that reported SOT recipients with post-transplant CMV (exposure) and without post-transplant CMV (non-exposure) who developed or did not develop subsequent IA. A random-effects model was used to calculate the pooled effect estimate. A total of 16 studies were included for systematic review and meta-analysis. There were 5437 SOT patients included in the study, with 449 SOT recipients developing post-transplant IA. Post-transplant CMV significantly increased the risk of subsequent IA with pORs of 3.31 (2.34, 4.69), I
Sections du résumé
BACKGROUND
BACKGROUND
Cytomegalovirus (CMV) and invasive aspergillosis (IA) cause high morbidity and mortality in solid organ transplant (SOT) recipients. There are conflicting data with respect to the impact of CMV on IA development in SOT recipients.
METHODS
METHODS
A literature search was conducted from existence through to 2 April 2021 using MEDLINE, Embase, and ISI Web of Science databases. This review contained observational studies including cross-sectional, prospective cohort, retrospective cohort, and case-control studies that reported SOT recipients with post-transplant CMV (exposure) and without post-transplant CMV (non-exposure) who developed or did not develop subsequent IA. A random-effects model was used to calculate the pooled effect estimate.
RESULTS
RESULTS
A total of 16 studies were included for systematic review and meta-analysis. There were 5437 SOT patients included in the study, with 449 SOT recipients developing post-transplant IA. Post-transplant CMV significantly increased the risk of subsequent IA with pORs of 3.31 (2.34, 4.69), I
Identifiants
pubmed: 33922773
pii: jof7050327
doi: 10.3390/jof7050327
pmc: PMC8145336
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Infect Chemother. 2016 Feb;22(2):84-9
pubmed: 26683245
Am J Transplant. 2009 Nov;9(11):2453-8
pubmed: 19843027
Am J Med. 1997 Aug;103(2):106-13
pubmed: 9274893
Clin Infect Dis. 1998 Mar;26(3):753-5
pubmed: 9524855
Am J Transplant. 2016 Jul;16(7):2148-57
pubmed: 26813515
N Engl J Med. 2008 Oct 23;359(17):1766-77
pubmed: 18946062
Chin Med J (Engl). 2013;126(17):3209-14
pubmed: 24033938
Clin Infect Dis. 2003 Jan 1;36(1):46-52
pubmed: 12491201
Clin Transplant. 2019 Sep;33(9):e13587
pubmed: 31077616
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Clin Exp Immunol. 2001 Feb;123(2):239-46
pubmed: 11207654
Transpl Infect Dis. 2014 Apr;16(2):340-3
pubmed: 24593162
Blood. 1997 Sep 15;90(6):2502-8
pubmed: 9310503
Am J Transplant. 2004 Apr;4(4):636-43
pubmed: 15023157
Transplantation. 1996 Feb 27;61(4):666-9
pubmed: 8610402
Int J Epidemiol. 2008 Oct;37(5):1148-57
pubmed: 18424475
Exp Clin Transplant. 2007 Dec;5(2):727-30
pubmed: 18194133
Lancet. 1997 Dec 13;350(9093):1729-33
pubmed: 9413463
Clin Infect Dis. 2010 Apr 15;50(8):1101-11
pubmed: 20218876
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376
pubmed: 31802125
Medicine (Baltimore). 1999 Mar;78(2):123-38
pubmed: 10195093
Liver Transpl. 2002 Nov;8(11):1065-70
pubmed: 12424722
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Transplant Direct. 2016 Jul 01;2(8):e90
pubmed: 27819031
Lancet Infect Dis. 2004 Dec;4(12):725-38
pubmed: 15567122
Clin Infect Dis. 2005 Jul 1;41(1):52-9
pubmed: 15937763
Clin Infect Dis. 2015 May 15;60(10):1505-11
pubmed: 25681376
J Antimicrob Chemother. 2003 Nov;52(5):813-9
pubmed: 14563893
J Clin Epidemiol. 2001 Oct;54(10):1046-55
pubmed: 11576817
J Clin Virol. 2006 Jun;36(2):146-51
pubmed: 16531113
Transplantation. 2020 Dec 14;:
pubmed: 33323766
J Heart Lung Transplant. 2001 Dec;20(12):1274-81
pubmed: 11744410
Transpl Infect Dis. 2015 Dec;17(6):779-84
pubmed: 26771688
Transpl Infect Dis. 2015 Feb;17(1):7-13
pubmed: 25573063
Liver Transpl. 2007 Apr;13(4):566-70
pubmed: 17394155
Transpl Infect Dis. 2018 Aug;20(4):e12898
pubmed: 29668068
Transplant Proc. 1996 Oct;28(5):2761-2
pubmed: 8908045
Clin Microbiol Infect. 2014 Feb;20(2):160-6
pubmed: 23607363
Clin Transplant. 2019 Sep;33(9):e13512
pubmed: 30817026
Clin Transplant. 2018 Aug;32(8):e13339
pubmed: 29956379
Infection. 2009 Aug;37(4):313-9
pubmed: 19629387
Clin Microbiol Infect. 2018 Feb;24(2):192-198
pubmed: 28652112
Am J Transplant. 2015 May;15(5):1141-7
pubmed: 25655091
N Engl J Med. 1999 May 13;340(19):1462-70
pubmed: 10320384
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120